You have full text access to this OnlineOpen article

Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects

  1. D. Aruna1,*,
  2. M. U. R. Naidu2

Article first published online: 29 SEP 2006

DOI: 10.1111/j.1365-2125.2006.02759.x

Issue

British Journal of Clinical Pharmacology

British Journal of Clinical Pharmacology

Volume 63, Issue 3, pages 333–338, March 2007

Additional Information

How to Cite

Aruna, D. and Naidu, M. U. R. (2007), Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. British Journal of Clinical Pharmacology, 63: 333–338. doi: 10.1111/j.1365-2125.2006.02759.x

Author Information

  1. 1

    Department of Clinical Pharmacology, Osmania General Hospital and

  2. 2

    Department of Clinical Pharmacology and Therapeutics, Nizam’s Institute of Medical Sciences, Hyderabad, India

*Dr D. Aruna, C/O Dr R. V. Kumar, 2-2-1144/22/A/2, New Nallakunta, Street No.3, Hyderabad-500044, Andhra Pradesh, India. Tel: + 91 040 3092 1264 Cell: + 91 040 98 4892 3036 E-mail:adonepudi@yahoo.co.in, kumarrv@rediff.com

Publication History

  1. Issue published online: 29 SEP 2006
  2. Article first published online: 29 SEP 2006
  3. Received 31 May 2006Accepted1 June 2006Published OnlineEarly29 September 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (102K)

References

  • 1
    Abebe. W. Herbal medications; potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002; 27: 391–401.
    Direct Link:
  • 2
    Ernest. E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002; 57: 891–6.
  • 3
    Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 2001; 61: 2163–75.
  • 4
    Beebe HG, Lawson DL, Cutler BS, Herd JA, Strandness DE Jr, Bortey EB, Forbes WP. A new pharmacological treatment for intermittent claudication. Arch Intern Med 1999; 159: 2041–50.
  • 5
    Thebault JJ, Kieffer G, Cariou R. Single dose pharmacodynamics of clopidogrel. Thromb Haemost 1999; 25: 3–8.
  • 6
    Coukell AJ, Markhan A. Clopidogrel. Drugs 1997; 54: 745–56.
  • 7
    Folium Ginkgo. In WHO Monographs on Selected Medicinal Plants, Vol. 1. Geneva: WHO 1999: 154–67.
  • 8
    Laffan MA, Manning RA. Investigation of haemostasis. In: Dacie and Lewis Practical Hematology, 9th edn, eds LewisSM, BainBJ, BatesI. London: Churchill Livingstone 2001: 339–90.
  • 9
    BcSH haemostasis and thrombosis task force. British Society for Haematology 1988 guidelines on platelet function testing. J Clin Pathol 1988; 41: 1322–30.
  • 10
    Born GVR. Quantitative investigation into aggregation of blood platelets. J Physiol 1962; 16: 68.
  • 11
    Rosenblat M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 336: 1108.
  • 12
    Matthews MK. Association of Ginkgo biloba with intracerebral haemorrhage. Neurology 1998; 50: 1933.
  • 13
    Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, Yun-Choi HS. Antiplatelet and antithrombotic effects of combination of ticlopidine and Ginkgo biloba extract (Egb 761). Thromb Res 1998; 91: 33–8.
  • 14
    Rowin J, Lewis SL. Spontaneous bilateral subdural haematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775–6.
  • 15
    Galluzi S, Zanetti O, Binnetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer’s disease taking low dose trazadone and Ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679–80.
  • 16
    Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barness PJ. Effect of Ginkgo glide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 1987; 1: 248–51.
  • 17
    Akiba S, Kawauchi T, Oka T, Hashizume T, Sato T. Inhibitory effect of leaf extract of Ginkgo biloba on oxidative stress induced platelet aggregation. Biochem Mol Biol Int 1998; 46: 1243–8.
  • 18
    Braquet P. The Ginkgo glides; potent platelet activating antagonists isolated from Ginkgo biloba L; chemistry, pharmacology and clinical applications. Drugs Future 1987; 12: 643–99.
  • 19
    Woo SK, Kang WK, Kwon KI. Pharmacokinetic and pharmacodynamic modeling of antiplatelet and cardiovascular effects of cilostazol in healthy humans. Clin Pharmacol Ther 2002; 71: 246–52.
  • 20
    Murada CH, Reilly P, Mohler ER. Cilostazol. Treatment of intermittent claudication. Ann Pharmacol Ther 2001; 35: 48–56.
View Full Article (HTML) Get PDF (102K)